Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354

Jochem B. Buil; Roger J.M. Brüggemann; Roeland E. Wasmann; Jan Zoll; Jacques F. Meis; Willem J.G. Melchers; Johan W. Mouton; Paul E. Verweij

doi:10.1093/jac/dkx425

Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354

Jochem B. Buil, Roger J.M. Brüggemann, Roeland E. Wasmann, Jan Zoll, Jacques F. Meis, Willem J.G. Melchers, Johan W. Mouton, Paul E. Verweij

Group Tissing

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

2 Citaten (Scopus)

Samenvatting

In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

Originele taal-2	Engels
Artikelnummer	dkx425
Pagina's (van-tot)	263
Aantal pagina's	1
Tijdschrift	Journal of Antimicrobial Chemotherapy
Volume	73
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1093/jac/dkx425
Status	Gepubliceerd - 1 jan. 2018

Toegang tot document

10.1093/jac/dkx425

Vingerafdruk

Duik in de onderzoeksthema's van 'Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354'. Samen vormen ze een unieke vingerafdruk.

Citeer dit

Buil, J. B., Brüggemann, R. J. M., Wasmann, R. E., Zoll, J., Meis, J. F., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2018). Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354. Journal of Antimicrobial Chemotherapy, 73(1), 263. Artikel dkx425. https://doi.org/10.1093/jac/dkx425

Buil, Jochem B. ; Brüggemann, Roger J.M. ; Wasmann, Roeland E. et al. / Erratum : Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354. In: Journal of Antimicrobial Chemotherapy. 2018 ; Vol. 73, Nr. 1. blz. 263.

@article{d10a1dae96744d9099edc02b99d2cd58,

title = "Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354",

abstract = "In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.",

author = "Buil, {Jochem B.} and Br{\"u}ggemann, {Roger J.M.} and Wasmann, {Roeland E.} and Jan Zoll and Meis, {Jacques F.} and Melchers, {Willem J.G.} and Mouton, {Johan W.} and Verweij, {Paul E.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1093/jac/dkx425",

language = "English",

volume = "73",

pages = "263",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "1",

}

Buil, JB, Brüggemann, RJM, Wasmann, RE, Zoll, J, Meis, JF, Melchers, WJG, Mouton, JW & Verweij, PE 2018, 'Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354', Journal of Antimicrobial Chemotherapy, vol. 73, nr. 1, dkx425, blz. 263. https://doi.org/10.1093/jac/dkx425

Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354. / Buil, Jochem B.; Brüggemann, Roger J.M.; Wasmann, Roeland E. et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 73, Nr. 1, dkx425, 01.01.2018, blz. 263.

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

TY - JOUR

T1 - Erratum

T2 - Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354

AU - Buil, Jochem B.

AU - Brüggemann, Roger J.M.

AU - Wasmann, Roeland E.

AU - Zoll, Jan

AU - Meis, Jacques F.

AU - Melchers, Willem J.G.

AU - Mouton, Johan W.

AU - Verweij, Paul E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

AB - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85040554974&partnerID=8YFLogxK

U2 - 10.1093/jac/dkx425

DO - 10.1093/jac/dkx425

M3 - Comment/debate

C2 - 29112717

AN - SCOPUS:85040554974

SN - 0305-7453

VL - 73

SP - 263

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 1

M1 - dkx425

ER -

Buil JB, Brüggemann RJM, Wasmann RE, Zoll J, Meis JF, Melchers WJG et al. Erratum: Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs [J Antimicrob Chemother, 73, (2018), (134-142)] DOI: 10.1093/jac/dkx354. Journal of Antimicrobial Chemotherapy. 2018 jan. 1;73(1):263. dkx425. doi: 10.1093/jac/dkx425